|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||
| Gain on sale of ATOM Facility | |||||
| Stock-based compensation expense | |||||
| Non-cash operating lease expense | |||||
| Depreciation and amortization expense | |||||
| Accretion of liability related to sale of future revenues | |||||
| Amortization (accretion) of investment premiums (discounts) | |||||
| Loss on impairment of lease right-of-use asset | |||||
| Gain on derecognition of lease liabilities upon contract assignment | |||||
| Other non-cash items, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued research and development expenses | |||||
| Other current liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Purchases of short-term investments | |||||
| Proceeds from maturities and sales of short-term investments | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Net proceeds from sale of ATOM Facility | |||||
| Net cash provided by investing activities | |||||
| Financing activities | |||||
| Proceeds from sale of common stock and pre-funded warrants in registered direct offerings, net | |||||
| Proceeds from issuance of common stock through ATM facilities, net | |||||
| Proceeds from employee stock awards | |||||
| Proceeds from sale of future revenues, net | |||||
| Taxes paid related to net share settlement of restricted stock units | |||||
| Principal payments on finance lease obligations | |||||
| Other financing activities, net | |||||
| Net cash provided by financing activities | |||||
| Decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Non-cash investing and financing activities | |||||
| Property and equipment purchases included in accounts payable and other accrued liabilities | |||||
| Accrued costs related to ATM facilities | |||||
| Proceeds from issuance of common stock through ATM facilities not yet received | |||||
| Accrued transaction costs related to sale of future revenues | |||||
| Supplemental cash flow disclosure | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
Loading...